CR10173A - Método para la utilización de células progenitoras hepáticas en el tratamiento de la disfunción hepática - Google Patents
Método para la utilización de células progenitoras hepáticas en el tratamiento de la disfunción hepáticaInfo
- Publication number
- CR10173A CR10173A CR10173A CR10173A CR10173A CR 10173 A CR10173 A CR 10173A CR 10173 A CR10173 A CR 10173A CR 10173 A CR10173 A CR 10173A CR 10173 A CR10173 A CR 10173A
- Authority
- CR
- Costa Rica
- Prior art keywords
- hepatic
- cells
- progeniting
- treatment
- dysfunction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Es una incorporación de la presente invención, se provee un método para repoblar el compartimiento del hígado de un mamifero el cual incluye proveer células progenitoras hepáticas aisladas y administrar dichas células progenitoras hepáticas aisladas dentro del compartimiento del hígado del mamifero; en donde la administración es llevada a cabo con concentraciones bajas de inmunosupresores.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75259705P | 2005-12-22 | 2005-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR10173A true CR10173A (es) | 2008-11-11 |
Family
ID=38218575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR10173A CR10173A (es) | 2005-12-22 | 2008-07-22 | Método para la utilización de células progenitoras hepáticas en el tratamiento de la disfunción hepática |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20070148141A1 (es) |
| EP (1) | EP1976982A4 (es) |
| JP (1) | JP2009521459A (es) |
| KR (1) | KR20080091776A (es) |
| AU (1) | AU2006331706A1 (es) |
| BR (1) | BRPI0620636A2 (es) |
| CA (1) | CA2634909A1 (es) |
| CR (1) | CR10173A (es) |
| IL (1) | IL192378A0 (es) |
| RU (1) | RU2008130098A (es) |
| TW (1) | TW200800241A (es) |
| WO (1) | WO2007075812A2 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2368384C2 (ru) * | 2007-08-24 | 2009-09-27 | Федеральное государственное учреждение "Научный Центр акушерства, гинекологии и перинатологии Федерального агентства по высокотехнологичной медицинской помощи" | Биотрансплантат, способ лечения хронических заболеваний печени и способ лечения цирроза печени и портальной гипертензии |
| WO2011102532A1 (ja) * | 2010-02-16 | 2011-08-25 | 国立大学法人九州大学 | 誘導肝細胞 |
| WO2013043662A1 (en) * | 2011-09-22 | 2013-03-28 | Marv Enterprises Llc | Method for the treatment of multiple sclerosis |
| US9532554B2 (en) | 2011-09-30 | 2017-01-03 | Public University Corporation Yokohama City University | Method for inducing hepatocellular variation, and production method for chimeric non-human animal having humanized liver |
| KR20180114032A (ko) * | 2016-01-08 | 2018-10-17 | 국립연구개발법인 고쿠리츠간켄큐센터 | 저분자 화합물에 의한 성숙 간세포로부터의 간 줄기/전구세포의 제작 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6069005A (en) | 1991-08-07 | 2000-05-30 | Albert Einstein College Of Medicine Of Yeshwa University | Hapatoblasts and method of isolating same |
| CA2877233A1 (en) * | 1999-01-19 | 2000-07-27 | Lola M. Reid | Human liver progenitors |
| US7456017B2 (en) | 1999-10-01 | 2008-11-25 | University Of North Carolina At Chapel Hill | Processes for clonal growth of hepatic progenitor cells |
| US20010046489A1 (en) * | 1999-12-06 | 2001-11-29 | Habener Joel E. | Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| HUE032238T2 (en) * | 2002-03-15 | 2017-09-28 | Univ North Carolina Chapel Hill | Primitive and proximal liver stem cells |
| RU2346981C2 (ru) * | 2002-07-19 | 2009-02-20 | Веста Терапьютикс, Инк. | Способ получения жизнеспособных клеток печени человека, в том числе печеночных стволовых клеток/клеток-предшественников |
-
2006
- 2006-12-21 AU AU2006331706A patent/AU2006331706A1/en not_active Abandoned
- 2006-12-21 WO PCT/US2006/048650 patent/WO2007075812A2/en not_active Ceased
- 2006-12-21 CA CA002634909A patent/CA2634909A1/en not_active Abandoned
- 2006-12-21 EP EP06848789A patent/EP1976982A4/en not_active Withdrawn
- 2006-12-21 RU RU2008130098/14A patent/RU2008130098A/ru not_active Application Discontinuation
- 2006-12-21 TW TW095148158A patent/TW200800241A/zh unknown
- 2006-12-21 US US11/614,703 patent/US20070148141A1/en not_active Abandoned
- 2006-12-21 JP JP2008547505A patent/JP2009521459A/ja active Pending
- 2006-12-21 KR KR1020087017909A patent/KR20080091776A/ko not_active Withdrawn
- 2006-12-21 BR BRPI0620636-0A patent/BRPI0620636A2/pt not_active Application Discontinuation
-
2008
- 2008-06-22 IL IL192378A patent/IL192378A0/en unknown
- 2008-07-22 CR CR10173A patent/CR10173A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200800241A (en) | 2008-01-01 |
| US20070148141A1 (en) | 2007-06-28 |
| EP1976982A4 (en) | 2009-09-16 |
| EP1976982A2 (en) | 2008-10-08 |
| AU2006331706A1 (en) | 2007-07-05 |
| WO2007075812A3 (en) | 2008-01-17 |
| KR20080091776A (ko) | 2008-10-14 |
| BRPI0620636A2 (pt) | 2011-11-16 |
| WO2007075812A2 (en) | 2007-07-05 |
| RU2008130098A (ru) | 2010-01-27 |
| CA2634909A1 (en) | 2007-07-05 |
| JP2009521459A (ja) | 2009-06-04 |
| IL192378A0 (en) | 2008-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009010683A (es) | Conjugado de wortmanina-rapamicina y usos del mismo. | |
| AR059089A1 (es) | Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal | |
| MX2014014117A (es) | Compuestos de d-aminoacidos para enfermedades del higado. | |
| WO2007095594A3 (en) | Methods and compositions for enhancing engraftment of hematopoietic stem cells | |
| CL2008001745A1 (es) | Compuestos derivados de imidazo[1,2-a]pirazina; composición farmacéutica; y uso de los compuestos como inhibidores de la proteína quinasa en el tratamiento del cáncer. | |
| MX2018002723A (es) | Macrociclicos peptidomimeticos y usos de los mismos. | |
| CL2012000248A1 (es) | Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina. | |
| CL2008001540A1 (es) | Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer. | |
| MX2014008773A (es) | Composiciones y metodos para el uso de ésteres de forbol. | |
| WO2007001662A3 (en) | Instant messaging with search | |
| CL2009000393A1 (es) | Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular. | |
| ATE494039T1 (de) | Gerät für die renale neuromodulation | |
| AR073563A1 (es) | Terapia de combinacion para el tratamiento de diabetes y estados relacionados | |
| ECSP088324A (es) | 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas | |
| AR077144A1 (es) | Derivado de fenilimidazol como inhibidor de la enzima pde10a, composiciones farmaceuticas y uso de los mismos en el tratamiento de trastornos neurodegenerativos y psiquiatricos | |
| AR060306A1 (es) | Terapia de combinacion de anticuerpos contra ctla4 | |
| MX2014014662A (es) | Manufactura de degarelix. | |
| DOP2009000208A (es) | Métodos de tratamiento del cáncer mediante administración de combinaciones de il-18 humana | |
| HN2006009000A (es) | Formas farmaceuticas con propiedades farmacocineticas mejoradas | |
| SV2008002856A (es) | 2-amino-7, 8-dihidro-6h-pirido [4,3-d] pirimidina-5-onas | |
| GT200800115A (es) | Metodos para tratar infecciones del tracto gastrointestinal con tigeciclina | |
| CL2011002812A1 (es) | Compuestos derivados de [1,2,4]triazolo[4,3-b]piridazinas; proceso de preparacion; y uso en el tratamiento del cancer a la prostata. | |
| MX2007004025A (es) | Uso de derivados del acido nordihidroguaiaretico en el tratamiento de cancer e infecciones microbial y viral resistente a farmacos._. | |
| ES2632933T3 (es) | Composición de limpieza de enzimas y método de uso | |
| AR107298A1 (es) | Método de purificación |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |